Publications by authors named "Shwe Gyaw"

6Publications

Pharmacokinetic Interaction between Naloxone and Naltrexone Following Intranasal Administration to Healthy Subjects.

Drug Metab Dispos 2019 07 16;47(7):690-698. Epub 2019 Apr 16.

National Institutes of Health, National Institute on Drug Abuse, Bethesda, Maryland (P.K., C.N.C., S.G., P.S.); and Sekisui XenoTech, LLC, Kansas City, Kansas (R.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/dmd.118.085977DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548978PMC
July 2019

Fighting Fire with Fire: Development of Intranasal Nalmefene to Treat Synthetic Opioid Overdose.

J Pharmacol Exp Ther 2019 11 2;371(2):409-415. Epub 2019 Apr 2.

National Institute on Drug Abuse, National Institutes of Health, Bethesda, Maryland (P.K., S.G.) and Opiant Pharmaceuticals, Santa Monica, California (R.C., P.S.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1124/jpet.118.256115DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6863453PMC
November 2019

Comparison of the Pharmacokinetic Properties of Naloxone Following the Use of FDA-Approved Intranasal and Intramuscular Devices Versus a Common Improvised Nasal Naloxone Device.

J Clin Pharmacol 2019 08 12;59(8):1078-1084. Epub 2019 Mar 12.

National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jcph.1401DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6606390PMC
August 2019

Placebo-controlled evaluation of a bioengineered, cocaine-metabolizing fusion protein, TV-1380 (AlbuBChE), in the treatment of cocaine dependence.

Drug Alcohol Depend 2016 Sep 28;166:13-20. Epub 2016 May 28.

Division of Therapeutics and Medical Consequences, National Institute on Drug Abuse, Bethesda, MD, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.drugalcdep.2016.05.019DOI Listing
September 2016